Moreover, Ochiai et al. recently reported a higher prevalence of distant recurrences, mainly BMs, among EGFR mutated tumors, compared with EGFR wild type, after definitive chemo-radiotherapy in stage III NSCLC [14]. Here, EGFR is linked to non-small cell lung carcinoma.